📰 Ronen Tsimerman News
Ronen Tsimerman News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ronen Tsimerman. Real-time updates on events, politics, business and more.
May 29, 2024
Operator: Good morning, and thank you for standing by. Currently, all participants are in a listen-only mode. After managements discussion, there will be a question-and-answer session.
April 4, 2024
Operator: Good morning and thank you for standing by. Currently, all participants are in a listen-only mode. After managements discussion, there will be a question-and-answer session.
May 24, 2023
Operator: Good morning and thank you for standing by. Currently, all participants are in a listen-only mode. After management’s discussion there will be a question-and-answer session.
March 31, 2023
Todd Kehrli: Thank you, Operator, and welcome to IceCure Medicals conference call to review the financial results for the 12 months ended December 31, 2022, and to provide an update on recent operational...
January 18, 2023
/PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the...
January 4, 2023
/PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the...
December 23, 2022
/PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the...
December 23, 2022
/PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the...
December 20, 2022
CAESAREA, Israel, Dec. 20, 2022 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) (IceCure or the Company), developer of minima...
December 20, 2022
/PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the...